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Abstract
Background: In rats, oral oleoyl-estrone (OE) decreases food intake and body lipid content. The
aim of this study was to determine whether OE treatment affects the energy metabolism of
pregnant rats and eventually, of their pups; i.e. changes in normal growth patterns and the onset of
obesity after weaning.
Methods: Pregnant Wistar rats were treated with daily intragastric gavages of OE in 0.2 ml
sunflower oil from days 11 to 21 of pregnancy (i.e. 10 nmol oleoyl-estrone/g/day). Control animals
received only the vehicle. Plasma and hormone metabolites were determined together with
variations in cellularity of adipose tissue.
Results: Treatment decreased food intake and lowered weight gain during late pregnancy, mainly
because of reduced adipose tissue accumulation in different sites. OE-treated pregnant rats'
metabolic pattern after delivery was similar to that of controls. Neonates from OE-treated rats
weighed the same as those from controls. They also maintained the same growth rate up to
weaning, but pups from OE-treated rats slowed their growth rate afterwards, despite only limited
differences in metabolite concentrations.
Conclusion:  The OE influences on pup growth can be partially buffered by maternal lipid
mobilization during the second half of pregnancy. This maternal metabolic "imprinting" may
condition the eventual accumulation of adipose tissue after weaning, and its effects can affect the
regulation of body weight up to adulthood.
Background
The administration of oleoyl-estrone (OE) (a naturally
occurring ester of estrone and fatty acids stored in adipose
tissue) to rats at pharmacological doses, induces a transi-
tory decrease in food intake, resulting in a noticeable
decrease in body weight that is not paralleled by any con-
current losses in body protein [1]. Since rats follow this
same pattern under different nutritional and physiologi-
cal conditions [2,3] hints at OE as a ponderostat (set-
point of body weight) regulator [4]. Although receptors
other than the estrogen receptor mediate OE effects [5] its
mechanism of action remains unknown, and involves
pathways different from those activated by food restric-
tion alone [6].
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It is well known that the availability of food during preg-
nancy affects the postnatal development of their litter [7].
The consequences of starvation or food deprivation are
well documented, in particular the high correlation
between maternal energy restriction and adult obesity [8].
Obesity is related to insulin resistance, hypertension and
dislipemia, factors that alone or combined decrease the
life span [9]. These effects are mediated, in part, by oxida-
tive processes linked to inflammation [10]. On the other
hand, there are evidences that energy restriction is associ-
ated with longer life span in rodents [11]. Thus, it can be
argued that the control of factors eliciting the onset of
obesity can also help decrease morbidity and mortality.
We have intended to determine whether OE-treatment
may affect pregnant rat descendants' growth pattern, since
OE reduces voluntary energy intake.
Methods
Animals
Female virgin Wistar rats from Harlan-Interfauna (Sant
Feliu de Codines, Spain) were mated with adult males
until impregnation (confirmed by the presence of sperma-
tozoa in daily vaginal smears); the day of impregnation
was designed as day 0 of pregnancy. The animals were
maintained in the Animal Service of the University of Bar-
celona, under standard conditions (light 12 hours on/off;
22°C, and 65% humidity) and had free access to standard
chow pellets (14.5% of protein, 4% of lipids, 4.5% of
fiber, 53.9% of starch and 10% of free sugars)(Panlab,
Barcelona, Spain) and tap water. All procedures were in
accordance with those guidelines governing the use of
experimental animals established by the European Union,
and were approved by the Animal Handling Ethics Com-
mittee of the University of Barcelona.
Treatment
On day 11 of pregnancy, a group of 6 animals was sacri-
ficed and used as a reference (P11 group). The remaining
animals were randomly divided into two groups (n = 12),
one receiving a daily gavage of 0.2 ml sunflower oil con-
taining 10 nmol oleoyl-estrone/g of body weight (OED,
Barcelona, Spain) (OE-treated group); and the other
receiving only the vehicle (Control group). The rats were
kept in individual cages, and their daily food consump-
tion and body weight were recorded. The gavages were
administered from days 11 to 21 of pregnancy. On day 21,
6 animals from each treatment group were sacrificed (P21
groups). The rest were sacrificed on day 20 after delivery
(L20 groups). 21-day fetuses (F21) and half of the 20-day
old pups (PP20) were beheaded and blood and adipose
tissue samples were obtained. The remaining PP20 pups
were placed in collective cages and sacrificed on day 30
(PP30) after birth. The weight of pups was recorded daily
after weaning, on day 20. Pregnant rats on days 11 and 21
were used in body composition analysis and energy bal-
ance calculations.
Samples
All pregnant rats and their pups were killed by swift decap-
itation. Blood was recovered and allowed to clot; serum
was frozen and stored at -80°C until processed. Samples
of white adipose tissue (WAT) from different locations
(perigonadal, retroperitoneal and mesenteric), and the
interscapular brown adipose tissue (IBAT) were immedi-
ately excised, frozen in liquid nitrogen, weighed and
stored at -80°C. Periovarian and epididymal samples
from pups were combined and used as a single perigo-
nadal sample. DNA content was measured using a stand-
ard fluorimetric method with 3, 5-diaminobenzoic acid
(Sigma, MO, USA) using bovine thymus DNA as standard
[4]. Since all mammalian cell nuclei contain the same
amount of DNA, we were able to estimate the approxi-
mate number of cells in a given WAT (or IBAT) sample by
dividing its DNA content by the mean DNA content of a
cell (6 pg/cell) [4]. The mean mass of the cells in a given
WAT site was determined by dividing the weight of the tis-
sue by the number of cells it contained [4,12].
Analytical procedures
Serum samples were used to measure glucose (Glucose
HK CP Kit, Horiva ABX, Madrid, Spain), urea (kit B8035
from Menarini, Firenze Italy), triacylglycerols (kit 11528;
Biosystems, Barcelona, Spain), total cholesterol (kit
B7576; Menarini), protein [13], HDL-cholesterol (precip-
itating kit CH204 from Randox, Crumlin UK; and kit
B7576 from Menarini), non-esterified fatty acids (NEFA)
(kit NEFA-C; Wako, Richmond, VA USA), 3-hydroxybu-
tyrate (kit 0907979; Boehringer-Mannheim, Mannheim,
Germany), insulin (rat insulin RIA kit; Linco, St Louis,
MO USA), adiponectin (mouse adiponectin RIA, Linco)
and leptin (rat leptin RIA, Linco). All commercial assays
were performed according to manufacturer's instructions.
Balances
After sampling, the stomach and intestinal contents were
discarded; the remaining rat carcasses were autoclaved,
homogenized and used to estimate water, protein, lipid
and energy content as previously described [2]. Briefly,
water was estimated by differential weighing before and
after desiccation at 110°C; protein was estimated from the
N content (Kjeldahl, using the 1007 Digestor and 1002
Distilling Unit, both part of a Tecator Kjeltec System,
Höganäs, Sweden) and conversion of the N content into a
protein equivalent [14]; lipid content was estimated by
trichloromethane: methanol extraction [15]; and total
energy by using a bomb calorimeter (C-7000 Ika, Heiter-
sheim, Germany). The final body composition was estab-
lished from the percentages of body components
measured experimentally and the estimated in vivo netReproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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body weight. For comparative balance calculations, we
used the mean body weight composition values of the
group killed at the beginning of the study (day 11).
The metabolizable energy content of the pellet food was
estimated from the standard caloric equivalence of its
assimilable components (154 g/kg crude protein, 605 g/
kg carbohydrate, 29 g/kg lipid) and the assumed efficiency
of the digestive process, giving a yield of 13.9 kJ/g. The
total energy content of the pellet was estimated using the
bomb calorimeter (16.5 kJ/g), which means that only
about 84 % of the total energy contained in the pellet
(including that from fiber) was taken up and used by the
rat [16].
Statistical comparison between groups was carried out
using two-way ANOVA and a post-hoc Bonferroni tests
using the program Prism 4 (GraphPad Software Inc, San
Diego, CA, USA). The unpaired Student's t test was used
for specific comparisons.
Results
In Fig. 1A are depicted the variations in weight of pregnant
rats along time. Specifically, control rats increased their
weight 118 ± 4 g from day 0 to day 21, whereas OE-treated
rats increased 65 ± 4 g. After parturition, both groups'
dams had the same weight. Fig. 1B shows that the pups
from OE-treated rats had a growth pattern similar to that
of controls from birth up to day 20. After weaning, the
treated group slowed its growth rate, significantly diverg-
ing from controls from day 27 onwards.
Changes in food intake of rats treated with OE during the  second half of pregnancy Figure 2
Changes in food intake of rats treated with OE dur-
ing the second half of pregnancy. The black bar indicates 
the period of treatment. P1, P11 and P21 refer to days 1, 11 
and 21 of pregnancy and L20 refers to day 20 after delivery. 
Statistical differences: two-way ANOVA; factor time (P < 
0.0001), factor treatment (P < 0.0001), significant interaction 
between factors (P = 0.0003). Bonferroni post-hoc test: 
There were significant differences between the groups from 
days 1, 16, 17 and 19 after delivery (* = P < 0.05).
Weight changes of OE-treated rats and their pups during  pregnancy Figure 1
Weight changes of OE-treated rats and their pups 
during pregnancy. A) Weight changes in dams. The black 
bar indicates the period of treatment. P1, P11 and P21 refer 
to days 1, 11 and 21 of pregnancy and L20 refers to day 20 
after delivery. Statistical differences: two-way ANOVA; fac-
tor time (P < 0.0001), factor treatment (P < 0.0001) and sig-
nificant interaction (P = 0.0001). Bonferroni post-hoc test: 
the weights of treated rats showed no differences. B) Weight 
changes in pups from control or OE-treated mothers during 
pregnancy. Statistical differences: two-way ANOVA; factor 
time (P < 0.0001), factor treatment (P < 0.0001), significant 
interaction between factors (P = 0.0002). Bonferroni post-
hoc test: * = P < 0.05. There were significant differences 
between groups from day 27 onwards.Reproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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The changes in daily food intake caused by treatment can
be seen in Fig. 2. Control animals ingested 1328 ± 62 g of
standard chow pellets during the entire study period,
whereas treated dams ingested 1193 ± 113 g (i.e. 89.8% of
controls). There were significant differences between
groups on days 1, 16, 17 and 19 of pregnancy.
Changes in serum metabolites during pregnancy and lac-
tation period, both in dams and their pups are shown in
Table 1. Transition from pregnancy to lactation induced
significant changes in almost all serum metabolites in the
dams, with increases in urea and cholesterol and decreases
in protein, non-esterified fatty acids and triacylglycerols.
OE treatment induced significant decreases in glucose and
HDL-cholesterol in late pregnancy, and in ketone bodies
and non-esterified fatty acids at weaning, whereas protein
levels were increased on day 20 after delivery. Transition
from fetal life to suckling pups brought significant
changes (essentially increases) in all parameters tested,
except for urea and 3-hydroxybutyrate. Pups from OE-
treated mothers showed significant increases in protein
and HDL-cholesterol and decreases in glucose on day 30
(PP30); the descendants from OE-treated dams showed
lowered glucose values in fetal life and in ketone bodies
on day 20, and increased protein values at weaning.
In Table 2, the levels of serum hormones are depicted. A
significant decrease in insulin and adiponectin progressed
Table 1: Serum metabolite values in pregnant and lactating rats and their fetuses/pups.
Pregnant/Lactating rats
P11 P21 L20 ANOVA
Glucose mM C 6.81 ± 0.20 6.98 ± 0.52 7.77 ± 0.11
OE 5.58 ± 0.48 * 6.87 ± 0.07
Protein g/l C 64.4 ± 1.42 64.5 ± 2.13 53.2 ± 1.01 T, TxTR
OE 63.4 ± 1.43 60.8 ± 2.16 *
Urea mM C 6.05 ± 0.32 5.29 ± 0.33 10.3 ± 0.41 T
OE 5.61 ± 0.71 11.1 ± 0.98
Non-esterified C 0.21 ± 0.01 0.95 ± 0.04 0.62 ± 0.10 T, TxTR
fatty acids mM OE 1.07 ± 0.04 0.41 ± 0.05 *
3OH butyrate μM C 93.2 ± 8.22 106 ± 15.3 90.1 ± 18.9 T
OE 99.8 ± 9.42 38.7 ± 3.53 *
Cholesterol mM C 0.88 ± 0.06 0.83 ± 0.07 3.74 ± 0.23 T, TxTR
OE 0.49 ± 0.06 4.11 ± 0.18
HDL Cholesterol mM C 0.44 ± 0.03 0.48 ± 0.08 0.34 ± 0.05
OE 0.30 ± 0.01 * 0.39 ± 0.06
Triacylglycerols mM C 1.25 ± 0.09 1.90 ± 0.04 0.52 ± 0.04 T
OE 1.93 ± 0.08 0.57 ± 0.06
Fetus/Pups
F21 PP20 PP30 ANOVA
Glucose mM C 4.01 ± 0.21 7.83 ± 0.11 8.84 ± 0.12 T, TR, TxTR
OE 3.16 ± 0.12 * 7.84 ± 0.09 8.12 ± 0.12 *
Protein g/l C 24.7 ± 1.40 40.8 ± 0.94 44.2 ± 1.74 T, TR, TxTR
OE 21.1 ± 0.40 49.6 ± 1.40 * 55.1 ± 1.21 *
Urea mM C 5.37 ± 0.83 5.79 ± 0.90 5.24 ± 0.38
OE 5.87 ± 0.70 4.36 ± 0.42 4.95 ± 0.58
Non-esterified C 0.24 ± 0.01 0.49 ± 0.06 0.59 ± 0.04 T
fatty acids mM OE 0.21 ± 0.02 0.57 ± 0.11 0.64 ± 0.01
3OH butyrate μM C 288 ± 3.64 250 ± 7.31 91.5 ± 14.1 T, TxTR
OE 297 ± 3.25 211 ± 15.9 * 108 ± 7.47
Cholesterol mM C 1.15 ± 0.06 3.46 ± 0.11 2.13 ± 0.09 T
OE 0.98 ± 0.13 3.27 ± 0.18 2.07 ± 0.01
HDL cholesterol mM C 0.12 ± 0.02 0.15 ± 0.01 0.18 ± 0.02 T, TxTR
OE 0.08 ± 0.03 0.15 ± 0.02 0.35 ± 0.08 *
Triacylglycerols mM C 0.27 ± 0.04 2.03 ± 0.01 1.67 ± 0.16 T
0.41 ± 0.11 1.91 ± 0.07 1.52 ± 0.13
C: control group; OE: treated group. Values are expressed as the mean ± s.e.m. of 6 animals per group. Statistical analysis of the differences: Two-
way ANOVA (time (T), treatment (TR) and interaction (TxTR)) was performed.
Post-hoc Bonferroni test (comparison between C and OE): * = P < 0.01Reproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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from late pregnancy to lactation. OE treatment decreased
leptin and adiponectin during late pregnancy. Developing
pups showed increased adiponectin both in control and
OE-treated groups. OE treatment caused a significant
increase in insulin at weaning and decreased leptin and
adiponectin on day 30 (PP30).
Body composition of pregnant rats on days 11 and 21 of
pregnancy, as well as the changes caused by OE treatment
are depicted in Table 3. These changes were determined by
comparing an ideal composition of each rat on day 11
(using the mean P11 body composition but their actual
day 11 weight) with their measured composition and
weight on the final day of treatment (P21). Our data show
that OE treatment induced a limited increase in body
weight, essentially a consequence of low lipid accrual.
Since protein content did not change, and lipid content
was reduced in OE-treated rats, the decrease in total
energy content in OE-treated rats was a consequence of
the decreased lipid content.
Table 3: Body composition of rats on days 11 and 21 of pregnancy.
P11 P21
Controls OE-treated
Body weight (g) 250 ± 5.8 335 ± 7.09 298 ± 10.6 *
Body composition
Lipid content (g) 33.9 ± 0.67 45.4 ± 0.99 30.6 ± 1.32 *
Protein content (g) 43.3 ± 0.86 48.6 ± 0.97 47.9 ± 1.47
Energy content (MJ) 2.18 ± 0.04 2.63 ± 0.006 2.06 ± 0.09 *
Changes in body composition
Body weight Absolute (g) 85.2 ± 7.04 46.5 ± 4.91 *
Relative (%) 34.1 ± 2.82 17.8 ± 1.61 *
Protein Absolute (g) 5.24 ± 1.05 3.85 ± 0.71
Relative (%) 12.1 ± 2.38 8.89 ± 1.48
Lipid Absolute (g) 11.8 ± 0.67 -3.10 ± 0.37 *
Relative (%) 34.8 ± 1.15 -9.14 ± 1.22 *
Energy (MJ) Absolute (g) 0.47 ± 0.03 -0.17 ± 0.03 *
Relative (%) 21.5 ± 1.36 -7.96 ± 1.30 *
Changes in body composition are shown, either in absolute or in relative values. The values are expressed as the mean + s.e.m. of 6 animals.
Statistical differences: * = P < 0.05 (OE-treated vs. controls).
Table 2: Serum hormone values in pregnant and lactating rats and in their pups.
Pregnant/Lactating rats
P11 P21 L20 ANOVA
Insulin nM C 0.38 ± 0.06 0.21 ± 0.04 0.18 ± 0.04
OE 0.18 ± 0.04 0.19 ± 0.04
Leptin nM C 0.17 ± 0.01 0.31 ± 0.07 0.09 ± 0.01 T, TR, TxTR
OE 0.10 ± 0.01* 0.10 ± 0.01
Adiponectin nM C 348 ± 39.8 279 ± 12.3 96.8 ± 25.2 T, TR, TxTR
OE 144 ± 7.97 * 95.3 ± 17.1
Pups
PP20 PP30 ANOVA
Insulin nM C 0.06 ± 0.01 0.10 ± 0.01 T, TxTR
OE 0.19 ± 0.03* 0.11 ± 0.01
Leptin nM C 0.10 ± 0.01 0.18 ± 0.02 TR, TxTR
OE 0.12 ± 0.01 0.07 ± 0.01*
Adiponectin nM C 60.7 ± 6.98 195 ± 12.9 T, TxTR
OE 69.3 ± 9.03 160 ± 9.93*
C: control group; OE: treated group. Values are expressed as the mean ± s.e.m. of 6 animals per group. Statistical analysis of the differences: Two-
way ANOVA (time (T), treatment (TR) and interaction (TxTR)) was performed.
Post-hoc Bonferroni test (comparison between C and OE): * = P < 0.01Reproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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Table 4: Adipose tissue weight, relative weight (% of body weight, bw), cell number and cell mass in pregnant rats and their pups.
Pregnant/Lactating rats
P11 P21 L20 ANOVA
Mesenteric WAT
Weight g C 4.30 ± 0.33 6.31 ± 0.40 0.73 ± 0.11 T, TR, TxTR
OE 3.43 ± 0.51 * 1.09 ± 0.17
Cell number n × 106 C 1076 ± 262 3382 ± 1415 408 ± 164 TxTR
OE 483 ± 104 * 681 ± 289
Cell mass ng C 3.90 ± 0.86 2.28 ± 1.22 2.27 ± 1.23 TxTR
OE 7.55 ± 0.46 * 2.88 ± 1.43
Retroperitoneal WAT
Weight g C 3.47 ± 0.42 4.69 ± 0.79 1.19 ± 0.05 T, TR, TxTR
OE 2.05 ± 0.20 * 1.36 ± 0.14
Cell number n × 106 C 228 ± 23.0 212 ± 34.5 87.4 ± 12.2 T, TR, TxTR
OE 99.4 ± 7.13 * 89.9 ± 3.09
Cell mass ng C 14.5 ± 0.31 20.2 ± 0.81 14.1 ± 1.98
OE 21.2 ± 2.72 15.4 ± 1.32
Perigonadal WAT
Weight g C 3.62 ± 0.42 7.44 ± 1.61 2.14 ± 0.61 T, TR, TxTR
OE 3.58 ± 0.71 * 2.19 ± 0.45
Cell number n × 106 C 324 ± 30.3 432 ± 23.9 207 ± 27.7 T, TR, TxTR
OE 243 ± 26.4 * 164 ± 28.8
Cell mass ng C 11.2 ± 0.78 18.7 ± 3.83 9.91 ± 1.74 T
OE 14.1 ± 1.44 14.6 ± 3.65
Interscapular IBAT
Weight mg C 330 ± 21.2 390 ± 91.2 340 ± 31.4
OE 391 ± 25.1 287 ± 26.6
Cell number n × 106 C 154 ± 13.9 92.9 ± 15.9 343 ± 4.21 T, TR, TxTR
OE 115 ± 10.3 191 ± 66.8 *
Cell mass ng C 2.20 ± 0.16 4.21 ± 0.39 0.98 ± 0.09 T, TxTR
OE 3.49 ± 0.28 2.31 ± 0.77
Pups
PP20 PP30 ANOVA
Mesenteric WAT
Weight g C 0.14 ± 0.03 0.45 ± 0.04 T, TR
OE 0.10 ± 0.02 0.31 ± 0.06 *
Cell number n × 106 C 189 ± 30.1 97.2 ± 6.51 TxTR
OE 44.2 ± 15.1 * 169 ± 25.3
Cell mass ng C 0.72 ± 0.07 2.97 ± 0.55 TR, TxTR
OE 4.65 ± 0.37 * 1.72 ± 0.23 *
Retroperitoneal WAT
Weight g C 0.05 ± 0.002 0.24 ± 0.03 T
OE 0.05 ± 0.001 0.16 ± 0.03 *
Cell number n × 106 C 16.4 ± 3.46 48.5 ± 10.3 T, TxTR
OE 7.22 ± 1.24 18.1 ± 4.32 *
Cell mass ng C 3.41 ± 0.56 5.65 ± 0.71 T, TxTR
OE 7.74 ± 1.14 * 8.03 ± 1.73
Perigonadal WAT
Weight g C 0.05 ± 0.007 0.19 ± 0.02 T
OE 0.03 ± 0.01 0.17 ± 0.04
Cell number n × 106 C 23.9 ± 4.80 41.7 ± 3.48 T, TR
OE 11.7 ± 1.27 47.9 ± 5.64
Cell mass ng C 1.74 ± 0.29 4.41 ± 0.39 TR
OE 2.55 ± 0.25 3.18 ± 0.25 *
Interscapular IBAT
Weight mg C 138 ± 20.1 184 ± 11.7 TxTR
OE 175 ± 17.4 147 ± 15.5
Cell number n × 106 C 74.1 ± 11.1 54.8 ± 7.47Reproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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Changes induced in the weight, cell number, and cell
mass of different adipose tissue depots, both in the dams
and their pups can be seen in Table 4. Although adipose
tissue weights increased throughout pregnancy, during
the transition to lactation they markedly decreased except
for IBAT. The loss of WAT was parallel to decreases in cell
number counts in all the locations, but also by increases
in brown adipose tissue cell number. OE treatment
reduced cell number in all WAT locations in late preg-
nancy, but not during lactation. In the pups, we observed
the expected increase in different adipose tissue locations
together with higher cell numbers in retroperitoneal and
perigonadal sites, but only increased mean cell mass in
the perigonadal site. The pups from OE-treated mothers
showed decreases in the weight (and a tendency towards
increased cell number) of mesenteric and perigonadal
pads (day 30), and decreased cell numbers in retroperito-
neal location.
Discussion
The aim of this study was to determine the effects of OE
treatment on pregnant rat metabolism; as expected, the
treatment with OE decreased food intake and dampened
increases in body weight during pregnancy. In fact, there
is discordance between the magnitude of total food
restriction and the weight loss this generates: i.e. a 10%
food limitation seems too small to cause a nearly 50 %
difference in weight increase (OE vs. controls) at the peak
of pregnancy. This can be viewed as a confirmation that
the slimming effects of OE are potent per se, i.e. not only
because it decreases dietary energy availability; in fact,
they are additive to those caused by food restriction, as
has been shown using pair-fed [6] and in food-deprived
lactation models [16]. Thus, the main effect of OE treat-
ment was the observed decrease in different adipose tissue
depots, since in late pregnancy the weight of individual
adipose depots measured only 50% of those of controls.
These data are validated by our balance energy analysis, in
which the difference in total weight was a consequence of
both a slower rate of protein accretion and a net loss of
lipid. This maybe critical in the dams' catabolic context of
the last third of pregnancy [17], when OE treatment selec-
tively increased the catabolism of lipid and exerted only
limited effects on protein metabolism and on the mainte-
nance of glucose homeostasis, in a way similar to that pre-
viously described [2].
The mild effects of OE treatment on intermediate metab-
olism during pregnancy give support to the assumption of
OE acting selectively on lipid stores. In addition, they
establish a pattern different from that of the more aggres-
sive food restriction models, in which normal develop-
ment of the feto-placental unit depends on the extent of
restriction [18]. This may help explain the important
changes that pups of food restricted mothers undergo fol-
lowing delivery [19]. These changes, which may deeply
determine their otherwise normal development [20] and
body balance control in adulthood [21] are minor in our
model. As a consequence, we have to assume that OE
treatment causes a selective mobilization of maternal
lipid stores in order to protect the near-normal develop-
ment of the conceptus at the expense of mother's reserves.
Since the differences in food intake of pregnant rats are
maximal in late pregnancy, it is unlikely that the normal
weight shown by pups at delivery will be a consequence of
altered maternal food intake pattern; thus, the stable
weight must be a consequence of OE treatment. Further-
more, this protective maternal pattern allows the normal
growth of fetuses, resulting in smaller differences in
weight at delivery, as well as in similar normal growth
rates with controls up to weaning, a buffering model that
differs completely from that described for the growth of
pups from dams treated with OE during lactation [16].
Which mechanism induces this selective pattern?
Although we cannot answer this question yet, the activa-
tion of apoptotic mechanisms by OE treatment in adipose
tissue [22] may contribute to lipid mobilization. Moreo-
ver, OE treatment produces minor changes in the meta-
bolic parameters of pregnant rats, as shown by the low
levels of HDL-cholesterol and glucose, which were the
only significant changes, observed in agreement with pre-
vious reports [2]. In addition, the maintenance of insulin
levels under OE treatment reinforces the maintenance of
insulin-glucose homeostasis in spite of decreased leptin
and adiponectin levels. This fall in leptin during late preg-
nancy is consistent with previous results [23], and proba-
bly is a direct consequence of adipose tissue depletion.
The decrease in leptin levels of lactating dams, however,
may result from its suppressed release in response to food
intake [24]. In addition, the decreased adipose depots sug-
gest that OE may be ineffective in reducing this response.
OE 54.7 ± 6.65 45.5 ± 7.41
Cell mass ng C 1.77 ± 0.13 4.19 ± 0.55 T, TxTR
OE 3.65 ± 0.31 * 2.62 ± 0.01
Values are expressed as the mean ± s.e.m. of 6 animals. In pups the samples of perigonadal adipose tissue were a mixture of periovarian and 
epididymal tissue. Statistical analysis of the differences: Two-way ANOVA (time (T), treatment (TR) and interaction (TxTR)) was performed. Post-
hoc Bonferroni test (comparison between C and OE): * = P < 0.01
Table 4: Adipose tissue weight, relative weight (% of body weight, bw), cell number and cell mass in pregnant rats and their pups. Reproductive Biology and Endocrinology 2008, 6:23 http://www.rbej.com/content/6/1/23
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It is possible that the differences in various adipose tissue
sites reflect their metabolic specialization, since the meta-
bolic activity of adipose tissue is not uniform nor is their
cell mass and the presence of non-adipocyte cells [25].
Thus, while the retroperitoneal location has long been
thought to serve as a storage site for readily usable lipids
during the lactation period [26], our results show that
during late pregnancy it remains undersized in the same
proportion as the perigonadal or mesenteric sites; thus,
contributing in a general way to the total loss of fat.
The consequences of OE treatment on pregnant rats were
minimal, since after delivery they recovered their food
intake levels up to weaning. However, OE-treated dams
also exhibited the expected decrease in total and specific
site lipid stores [16,23] resulting from the use of these lip-
ids to sustain milk production.
The minimal differences in plasma parameters of pups
from OE-treated rats vs. controls, and the minor changes
observed in the weight gained up to day 20 after birth, are
indicative of the maintenance of normal growth and unaf-
fected metabolism. Thus, the low leptin levels observed in
pups [23] must be a consequence of the initially limited
adipose tissue masses that progressively grow thereafter.
Food intake restriction has been found to improve meta-
bolic and functional parameters in rats [27]. Conse-
quently, if this restriction is regarded as an ambiental
condition suffered by pregnant rats, we can assume that
the normal development of their pups would be affected.
Thus, maternal OE treatment could induce selective sig-
nals that limit the normal growth of adipose tissue depots
in their pups, thereby improving their chances of survival,
and limiting the appearance of complications associated
with the onset of obesity. These effects are specifically
related to OE, since they are not paralleled by estrogen sig-
naling: OE neither binds the estrogen receptor [5] nor
increases body weight [28]. Furthermore, as OE treatment
preserves body protein, any possible reduction in life span
due to protein restriction in utero [29] is very probably
minimized. These findings enhance the possible utiliza-
tion of OE as experimental drug to prevent the develop-
ment of obesity in later life.
Conclusion
The pregnant rats can buffer the effects of OE treatment,
mobilizing their own energy stores that can be used by
their offspring, and generating simultaneously a meta-
bolic imprinting in their pups that limits the accretion of
adipose tissue, thereby reducing their pups' risk for devel-
oping obesity in adulthood.
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